Chloral hydrate

This substance was identified for action under the Chemicals Management Plan (CMP).

• Summary of publications
• Follow-up activites
• Information gathering
  • Section 71 CMP 2023
• Timelines

Summary of publications

CAS RN	Common name	DSL name	Public comments on the draft screening assessment	Final screening assessment	Conclusion on section 64 criteria	Follow-up activities
302-17-0	Chloral hydrate	1,1-Ethanediol, 2,2,2-trichloro-	HTML	HTML	Does not meet	Information gathering

Follow-up activities

While exposure of the general population to chloral hydrate is not of concern at current levels, this substance is considered to have a health effect of concern on the basis of its potential carcinogenicity. Therefore, there may be a concern for human health if exposures were to increase. Follow-up activities will involve including the substance in future information gathering initiatives, such as a mandatory survey under section 71 of the Canadian Environmental Protection Act, 1999 (CEPA 1999). Stakeholders will be given advance notice of any planned information gathering.

Information gathering

Section 71 CMP 2023

In June 2023, a notice was published in the Canada Gazette, Part I: Vol. 157, No. 25 – June 24, 2023 under section 71 of CEPA 1999. This notice applies to chloral hydrate (CAS RN 302-17-0). More information is available on the Information gathering with respect to certain substances under the Chemicals Management Plan web page.

Timelines

Date	Activity
June 24, 2023	Publication in Canada Gazette, Part I, of a notice under section 71 of CEPA 1999.
October 7, 2017	Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 151, No. 40.
December 17, 2016	Publication and start of 60-day public comment period on the draft screening assessment (including follow-up activities). The related notice was published in the Canada Gazette, Part I: Vol. 150, No. 51.